Summer Haven Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Summer Haven Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	BUY	$28.51 - $32.9 $42,907 - $49,514	1,505 Added 4.76%	33,123 $1.07 Million
Q3 2021 Oct 20, 2021	BUY	$23.54 - $31.39 $314,329 - $419,150	13,353 Added 73.11%	31,618 $843,000
Q2 2021 Jul 28, 2021	BUY	$26.72 - $33.19 $12,264 - $15,234	459 Added 2.58%	18,265 $562,000
Q4 2020 Feb 17, 2021	SELL	$17.7 - $25.81 $7.61 Million - $11.1 Million	-430,193 Reduced 96.03%	17,806 $448,000
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $7.93 Million - $11.6 Million	447,999 New	447,999 $448,000

302

60.6M

25.2K

2.6K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.09B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Summer Haven Investment Management, LLC with notifications on news.